SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 31.31 |
Enterprise Value ($M) | 11.93 |
Book Value ($M) | 13.72 |
Book Value / Share | 2.98 |
Price / Book | 2.28 |
NCAV ($M) | 10.96 |
NCAV / Share | 2.38 |
Price / NCAV | 2.86 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.77 |
Return on Assets (ROA) | -0.64 |
Return on Equity (ROE) | -3.47 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.07 |
Current Ratio | 3.07 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 58.85 |
Assets | 61.61 |
Liabilities | 47.89 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | ADAR1 Capital Management, LLC | 9.99 | ||
13D | Sr One Capital Management, Llc | 9.99 | ||
13D | Baker Bros. Advisors Lp | 19.99 | 231.09 | |
13G | Millennium Management Llc | 5.00 | ||
13G/A | Checkpoint Capital L.P. | 0.00 | -100.00 | |
13G/A | Integrated Core Strategies (us) Llc | 4.90 | -0.77 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
10,956 | 71,872 | 15.24 | |
2,271 | 17,955 | 12.65 | |
1,603 | 72,758 | 2.20 | |
7,486 | 23,482 | 31.88 | |
(click for more detail) |
Similar Companies | |
---|---|
ITRM – Iterum Therapeutics plc | JAGX – Jaguar Health, Inc. |
JSPR – Jasper Therapeutics, Inc. | KPRX – Kiora Pharmaceuticals, Inc. |
KRRO – Korro Bio, Inc. |
Financial data and stock pages provided by
Fintel.io